2026 Cancer Research Grant Recipients
Dr. Peter Tsvetkov
2026Beth Israel Deaconess Medical Center, Inc.
Assistant Professor, Department of Pathology
Cuproptosis as a Therapeutic Strategy in High-Grade Serous Ovarian Cancer
Dr. Qing Chen
2026Associate Professor
Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
Decoding the Steroid Induced Tumor Microenvironment in Breast Cancer Brain Metastasis
Dr. Mikala Egeblad
2026Professor
The Johns Hopkins University School of Medicine
Macrophages control ER stress adaptation and chemoresistance in ovarian cancer
Dr. Xinyan Wu, PhD
2026Assistant Professor of Pharmacology
Mayo Clinic Rochester
A Dual-Action Therapeutic Strategy: Targeting TNK2 Kinase to Suppress Endometrial Cancer and Enhance Antitumor Immunity
Dr. Daniel Heller
2026Member, Molecular Pharmacology Program
Memorial Sloan Kettering Cancer (together with Memorial Hospital for Cancer and Allied Diseases and Sloan Kettering Institute for Cancer Research)
Liquid Biopsy for Ovarian Cancer Incidence and Recurrence Risk
Dr. Neil Vasan
2026Director of Translational Breast Cancer Research
NYU Grossman School of Medicine
Genomic Determinants of PI3K/AKT Pathway Dependence and Targeted Therapy Response in Endometrioid Endometrial Cancer
Dr. Sandra Orsulic
2026Professor
The Regents of the University California, Los Angeles (dba UCLA)
Durable Ovarian Cancer Immunoprevention After Prophylactic Surgery
Dr. Lucia Borriello
2026Assistant Professor
Temple University
Targeting Systemic Changes Induced by Chemotherapy to Prevent Awakening of Dormant Tumor Cells and Metastatic Outgrowth in TNBC patients
Dr. Srinivas Malladi
2026Associate Professor, Department of Pathology
UT Southwestern Medical Center
Targeting AKT3 to Overcome Immunotherapy Resistance in Breast Cancer Brain Metastasis
Dr. Justin Balko
2026Professor of Medicine
Vanderbilt University Medical Center
Isolated losses of individual HLAs as a mechanism of tumor immune evasion and biomarker of immunotherapy response in women’s cancers
2025 Cancer Research Grant Recipients
Anne Van Arsdale, MD, MSc
2025Albert Einstein College of Medicine
Associate Professor
Pathogenic role of extrachromosomal DNA (ecDNA) with human papillomavirus (HPV) DNA integration in cervical carcinoma
Dr. Na Zhao
2025Assistant Professor
Baylor College of Medicine
Targeting eIF4A to Combat Established Metastatic Triple-Negative Breast Cancer
Dr. Li Lily Lan
2025Associate Professor
Duke University
Targeting the mRNA Methyltransferase TRDMT1 in Ovarian and Breast Cancer
Dr. Harikrishna Nakshatri
2025Marian J. Morrison Professor of Breast Cancer Research
Indiana University
Deciphering aberrant epithelial-endothelial-fibroblast interactions in inflammatory breast cancer
Dr. Junran Zhang
2025Professor
The Ohio State University
Targeting SQLE to Enhance Immunotherapy for Breast Cancer
Dr. Livnat Jerby
2025Assistant Professor
Stanford University
Redirecting adoptive and endogenous T cells to target Her2+ breast cancer tumors
Dr. Li Lily Wang
2025Staff
Cleveland Clinic
Targeting a novel immune checkpoint receptor for the treatment of Triple-Negative Breast Cancer
Dr. Charles Ishak
2025Assistant Professor
The University of Texas M.D. Anderson Cancer Center
UBA1 as a therapeutic opportunity to eliminate immune-refractory ovarian tumors
Dr. Uttam Tambar
2025Bonnie Bell Harding Professor in Biochemistry
University of Texas Southwestern Medical Center
Targeted Degradation of KAT7 for the Treatment of Aggressive Breast Cancer
Dr. Benjamin Hopkins
2025Assistant Professor
Weill Medical College
Targeting Cullin-RING E3 Ubiquitin Ligase 1 to treat ovarian cancer
2024 Cancer Research Grant Recipients
Maria Soledad Sosa, PhD
2024Associate Professor
Albert Einstein College of Medicine
Targeting dormant disseminated breast cancer cells to prevent metastasis formation
Gloria Echeverria, PhD
2024Assistant Professor
Baylor College of Medicine
Disrupting mitochondrial translation in chemoresistant triple negative breast cancer to overcome metabolic vulnerabilities
Sichun Yang, PhD
2024Associate Professor
CWRU Case Comprehensive Cancer Center
Targeting intrinsic ERalpha disorder to overcome antiestrogen resistance
Jennifer Hope, PhD
2024Assistant Professor
Drexel University
Targeting PSGL-1 to promote immune checkpoint blockade responsiveness in treatment-resistant triple negative breast cancer
Adrienne Boire, MD, PhD
2024Geoffrey Beene Junior Faculty Chair, Associate Attending Neurologist, Associate Member Human Oncology and Pathogenesis Program
Memorial Sloan Kettering Cancer Center
Breast Cancer Communication Across Brain Barriers
Erin Howe, PhD
2024Assistant Professor of Biochemistry and Molecular Biology, Center for Proteomics and Molecular Therapeutics
Rosalind Franklin University of Medicine & Science
Rab11 family interacting proteins control immune recognition of breast cancer brain metastases
Scott Abrams, PhD
2024Chair, Department of Immunology; Jacobs Family Endowed Chair of Immunology; Professor of Oncology
Roswell Park Comprehensive Cancer Center
Targeting the Immune Suppressive Tumor Microenvironment in Triple-Negative Breast Cancer to Improve Chemo-Immunotherapy Outcomes
Swarnali Acharyya, PhD
2024Associate Professor
The Trustees of Columbia University in the City of New York
Targeting PGF-FLT1 tumor microenvironment interactions to overcome PARP inhibitor resistance in breast cancer
Ernst Lengyel, PhD
2024Professor, Gynecologic Oncology
The University of Chicago
Methylation-based biomarkers for the detection and stratification of ovarian cancer in high-risk women
Pengda Liu, PhD
2024Associate Professor
The University of North Carolina at Chapel Hill
Statins suppress breast cancer metastasis by controlling canonical and non-canonical 2’3’-cGAMP signaling
Sarwish Rafiq, PhD
2024Assistant Professor
Emory University
Engaging the endogenous immune system using immune checkpoint inhibitors and CAR T cells
Lingtao Jin, PhD
2024Associate Professor, Department of Molecular Medicine
The University of Texas Health Science Center at San Antonio
Targeting novel protein kinase to improve taxane-based chemotherapy in ovarian cancer